SCHEDULE: Adage Capital Management Discloses Stake in EyePoint Inc.

Adage Capital Management, L.P. and associated individuals have reported beneficial ownership of 3,300,000 shares, representing 3.96% of EyePoint, Inc.'s common stock as of March 31, 2026.

Summary

• Adage Capital Management, L.P. (ACM), along with Robert Atchinson and Phillip Gross, has filed a Schedule 13G, indicating their beneficial ownership of EyePoint, Inc. common stock.
• The filing reports a total of 3,300,000 shares owned, which constitutes 3.96% of the company's outstanding common stock.
• This ownership level is based on the 83,431,950 shares outstanding as of February 27, 2026, as reported in EyePoint's Form 10-K for the fiscal year ended December 31, 2025.
• The reporting persons, including ACM, Robert Atchinson, and Phillip Gross, have shared voting and dispositive power over these shares.
• The filing asserts that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports ownership and does not contain operational or financial performance data for EyePoint, Inc.

Positives

• Adage Capital Management's investment indicates confidence in EyePoint, Inc.'s potential, which could be viewed positively by the market.
• The disclosure of a significant stake (3.96%) by an established investment manager like Adage Capital Management can attract further investor interest.

Negatives

• The filing does not contain any negative financial results or operational challenges for EyePoint, Inc.

Risks

• The filing does not explicitly mention any current issues or potential future challenges for EyePoint, Inc.

Future Outlook

The filing does not contain any forward-looking statements or guidance from EyePoint, Inc. It solely reports on beneficial ownership.

Management Comments

• "The filing of this statement should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the securities reported herein."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors acquiring a significant stake in a public company. Adage Capital Management's filing for EyePoint, Inc. suggests a strategic investment, typical in the biotechnology or pharmaceutical sectors where such firms often seek to influence or support company growth.

Stakeholder Impact

• Shareholders: The filing may signal increased institutional interest in EyePoint, Inc., potentially influencing share price and liquidity.
• Management: The reporting persons have stated they are not seeking to influence control, suggesting a passive investment approach for now.

Next Steps

• Adage Capital Management will continue to hold its shares in EyePoint, Inc. in the ordinary course of business.
• EyePoint, Inc. will continue its operations as detailed in its previous filings.

Key Dates

Keywords

EyePoint Inc., Schedule 13G, Adage Capital Management, Beneficial Ownership, SEC Filing, Common Stock, Investment Management, Robert Atchinson, Phillip Gross